These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24125035)

  • 1. Targets for intervention to improve virological outcomes for patients receiving free antiretroviral therapy in Tamil Nadu, India.
    McMahon JH; Manoharan A; Wanke C; Mammen S; Jose H; Malini T; Kadavanu T; Jordan MR; Elliott JH; Lewin SR; Mathai D
    AIDS Care; 2014; 26(5):559-66. PubMed ID: 24125035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.
    Orrell C; Harling G; Lawn SD; Kaplan R; McNally M; Bekker LG; Wood R
    Antivir Ther; 2007; 12(1):83-8. PubMed ID: 17503751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved virological suppression in children on antiretroviral treatment receiving community-based adherence support: a multicentre cohort study from South Africa.
    Fatti G; Shaikh N; Eley B; Grimwood A
    AIDS Care; 2014 Apr; 26(4):448-53. PubMed ID: 24215157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacy and self-report adherence measures to predict virological outcomes for patients on free antiretroviral therapy in Tamil Nadu, India.
    McMahon JH; Manoharan A; Wanke CA; Mammen S; Jose H; Malini T; Kadavanu T; Jordan MR; Elliott JH; Lewin SR; Mathai D
    AIDS Behav; 2013 Jul; 17(6):2253-9. PubMed ID: 23435750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profile of HIV-infected patients receiving second-line antiretroviral therapy in a resource-limited setting in Nigeria.
    Onyedum CC; Iroezindu MO; Chukwuka CJ; Anyaene CE; Obi FI; Young EE
    Trans R Soc Trop Med Hyg; 2013 Oct; 107(10):608-14. PubMed ID: 23959002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to antiretroviral adherence in HIV-positive patients receiving free medication in Kayunga, Uganda.
    Senkomago V; Guwatudde D; Breda M; Khoshnood K
    AIDS Care; 2011 Oct; 23(10):1246-53. PubMed ID: 21939403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study.
    Weber R; Huber M; Battegay M; Stähelin C; Castro Batanjer E; Calmy A; Bregenzer A; Bernasconi E; Schoeni-Affolter F; Ledergerber B;
    HIV Med; 2015 Mar; 16(3):137-51. PubMed ID: 25124393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time patterns of adherence and long-term virological response to non-nucleoside reverse transcriptase inhibitor regimens in the Stratall ANRS 12110/ESTHER trial in Cameroon.
    Meresse M; Carrieri MP; Laurent C; Kouanfack C; Protopopescu C; Blanche J; Cohen J; Laborde-Balen G; Aghokeng AF; Spire B; Moatti JP; Delaporte E; Boyer S;
    Antivir Ther; 2013; 18(1):29-37. PubMed ID: 23358393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of associations and development of atazanavir resistance after unplanned treatment interruptions.
    Tinago W; O'Halloran JA; O'Halloran RM; Macken A; Lambert JS; Sheehan GJ; Mallon PW
    HIV Med; 2014 Apr; 15(4):224-32. PubMed ID: 24215370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia.
    Aghokeng AF; Monleau M; Eymard-Duvernay S; Dagnra A; Kania D; Ngo-Giang-Huong N; Toni TD; Touré-Kane C; Truong LX; Delaporte E; Chaix ML; Peeters M; Ayouba A;
    Clin Infect Dis; 2014 Jan; 58(1):99-109. PubMed ID: 24076968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of use of alcohol and illicit drugs by AIDS patients on adherence to antiretroviral therapy in Bahia, Brazil.
    Teixeira C; Dourado Mde L; Santos MP; Brites C
    AIDS Res Hum Retroviruses; 2013 May; 29(5):799-804. PubMed ID: 23294471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virological response and HIV drug resistance 12 months after antiretroviral therapy initiation at 2 clinics in Nigeria.
    Ugbena R; Aberle-Grasse J; Diallo K; Bassey O; Jelpe T; Rottinghaus E; Azeez A; Akpan R; Muhammad M; Shanmugam V; Singh S; Yang C
    Clin Infect Dis; 2012 May; 54 Suppl 4():S375-80. PubMed ID: 22544206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. System-level factors as predictors of adherence to clinical appointment schedules in antiretroviral therapy in Cambodia.
    Daigle GT; Jolly PE; Chamot EA; Ehiri J; Zhang K; Khan E; Sou S
    AIDS Care; 2015; 27(7):836-43. PubMed ID: 25803006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians.
    Grierson J; Koelmeyer RL; Smith A; Pitts M
    HIV Med; 2011 Oct; 12(9):562-9. PubMed ID: 21554524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of second-line antiretroviral treatment in an adult and adolescent cohort in Myanmar.
    Kyaw NTT; Kumar AMV; Oo MM; Oo HN; Kyaw KWY; Thiha S; Aung TK; Win T; Mon YY; Harries AD
    Glob Health Action; 2017; 10(1):1290916. PubMed ID: 28594295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda.
    Franke MF; Kaigamba F; Socci AR; Hakizamungu M; Patel A; Bagiruwigize E; Niyigena P; Walker KD; Epino H; Binagwaho A; Mukherjee J; Farmer PE; Rich ML
    Clin Infect Dis; 2013 May; 56(9):1319-26. PubMed ID: 23249611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of genotypic resistance testing on selection of salvage regimen in clinical practice.
    Haupts S; Ledergerber B; Böni J; Schüpbach J; Kronenberg A; Opravil M; Flepp M; Speck RF; Grube C; Rentsch K; Weber R; Günthard HF;
    Antivir Ther; 2003 Oct; 8(5):443-54. PubMed ID: 14640392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mobile telephone reminders on treatment outcome in HIV: evidence from a randomised controlled trial in India.
    Shet A; De Costa A; Kumarasamy N; Rodrigues R; Rewari BB; Ashorn P; Eriksson B; Diwan V;
    BMJ; 2014 Oct; 349():g5978. PubMed ID: 25742320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination SMS and transportation reimbursement intervention to improve HIV care following abnormal CD4 test results in rural Uganda: a prospective observational cohort study.
    Siedner MJ; Santorino D; Lankowski AJ; Kanyesigye M; Bwana MB; Haberer JE; Bangsberg DR
    BMC Med; 2015 Jul; 13():160. PubMed ID: 26149722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians.
    Souza IE; Zhang W; Diaz RS; Chaloner K; Klinzman D; Stapleton JT
    HIV Med; 2006 Jan; 7(1):25-31. PubMed ID: 16313289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.